Immediate Impact

2 from Science/Nature 59 standout
Sub-graph 1 of 22

Citing Papers

The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
2 intermediate papers

Works of Hua He being referenced

MicroRNA-497-5p down-regulation increases PD-L1 expression in clear cell renal cell carcinoma
2018

Author Peers

Author Last Decade Papers Cites
Hua He 368 105 195 32 568
Xiaoyan Lan 270 89 143 31 598
Pierre‐Olivier Guichet 364 148 162 23 645
Jian Chen 291 68 127 30 519
Jorge A. Benítez 314 62 73 29 510
Chaomei Xiang 365 62 119 15 528
Falk Hertwig 317 83 146 20 518
Masoumeh Fakhr Taha 382 183 172 37 632
Weiming Zheng 233 119 91 37 629
Jessica Schira‐Heinen 296 164 127 24 593
Angela Garding 409 48 97 14 534

All Works

Loading papers...

Rankless by CCL
2026